| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.33B | 36.80B | 36.29B | 30.45B | 35.38B | 37.30B |
| Gross Profit | 8.62B | 8.58B | 8.26B | 6.45B | 7.41B | 8.90B |
| EBITDA | 7.53B | 7.53B | 7.15B | 5.49B | 6.11B | 7.29B |
| Net Income | 2.89B | 3.06B | 2.89B | 1.84B | 2.28B | 5.36B |
Balance Sheet | ||||||
| Total Assets | 58.99B | 64.15B | 60.73B | 58.62B | 55.47B | 56.60B |
| Cash, Cash Equivalents and Short-Term Investments | 14.66B | 14.82B | 16.64B | 16.23B | 15.10B | 15.89B |
| Total Debt | 5.58B | 5.55B | 5.56B | 5.12B | 4.14B | 5.59B |
| Total Liabilities | 14.58B | 16.09B | 15.73B | 14.11B | 12.31B | 13.87B |
| Stockholders Equity | 44.18B | 47.83B | 44.75B | 44.26B | 42.92B | 42.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.43B | 2.95B | 686.00M | 1.05B | 2.70B |
| Operating Cash Flow | 0.00 | 6.01B | 7.12B | 6.54B | 5.63B | 5.40B |
| Investing Cash Flow | 0.00 | -8.16B | -4.32B | -5.83B | -3.28B | -2.06B |
| Financing Cash Flow | 0.00 | 151.00M | -2.83B | -141.00M | -3.72B | -3.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥81.98B | 18.62 | 6.31% | 4.01% | 1.41% | 7.59% | |
74 Outperform | ¥108.88B | 18.70 | 15.07% | 1.74% | 7.82% | 64.90% | |
73 Outperform | ¥75.50B | 9.11 | ― | 3.04% | -0.37% | -20.95% | |
70 Outperform | ¥84.99B | 10.06 | ― | 3.74% | 0.53% | 30.98% | |
69 Neutral | ¥54.76B | 13.50 | ― | 2.92% | -5.24% | 17.53% | |
65 Neutral | ¥51.85B | 19.62 | ― | 4.37% | -3.84% | -43.55% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |